An innovative pharmaceutical company delivering novel women's reproductive healthcare products.
The Challenge
With many compliance-based limitations and the need to adopt a scalable DTC business model for a pharmaceutical company, we were challenged to design and implement an e-commerce ecosystem inclusive of demand driving, telehealth, and fulfillment to drive new patient acquisition and conversion for a modern birth control solution.
The Outcome
Our paid media campaigns are not only spend-efficient, having cut the average CPC by nearly 50%, but also highly effective, generating a ROAS of 3.8x.
CASE STUDY |
AGENCY SELECT
Pharmaceutical
Why We Engaged
With the consumerization of healthcare and telehealth adoption peaking due to pandemic related forces, a consumer-centric approach to patient acquisition was possible. Based on the capability limitations of conventional healthcare marketing firms, our partner’s high product margins and AOV, and a clear path in the data to impact the publicly traded share price.
Results
ROAS
x 3.8
CPC
-46%
CTR
+6.25%
TIMELINE
9 Mo.
Scope
Healthcare platform ecosystem development to enable DTC business model, CRO, web design, paid media strategy and management, data analytics, business strategy, financial modelling, advisory.
Strategy
● Design and develop telemd supported DTC ecosystem to facilitate new direct patient acquisition channel. ● Conduct full keyword and competitor research to discover high-intent bottom-funnel keywords. ● Implement a long-tail landing page strategy with an intuitive user journey to surpass competition and achieve growth objectives. ● Aggressively optimize campaigns, conduct ongoing testing, increase efficiency. ● Align program performance with company financials.
Results
● Achieved a consistent, industry-low average CPC of $3.27 - a reduction of 50%.
● Boosted on-page click through rate, generating 17% more leads contributing to revenue growth objectives.
● Quickly outranked established competitors, claiming the #5 spot in non-brand auction insights through creative copy.